Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Palma de Mallorca
Clinical trial register · Spain

Clinical Trials in Palma de Mallorca, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Palma de Mallorca

173 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Jaén, Málaga, Palma de Mallorca, Salamanca, Barcelona, L'Hospitalet de Llobregat, Valencia, A Coruña
2027-11-23
Not yet open
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
158
Madrid, Palma de Mallorca
2026-11
Not yet open
A Paradigm Shift in Musculoskeletal Rehabilitation Assessment After ACL Reconstruction Using Near-Infrared Spectroscopy
NCT06621355ACL Injury, Hemodynamics, Oxygen Consumption Based Assessment of Hemodynamics, Exercise
Universitat de Lleida
Observational
129
Palma de Mallorca
2026-10-01
Not yet open
Personalised Behavioural Intervention in Cancer Screening Programmes
NCT07722442Dietary and Lifestyle Behaviour Change
Fundació d'investigació Sanitària de les Illes Balears
Not applicable
162
Palma de Mallorca
2026-10-01
Recruiting
Kardigan, Inc.
Phase 3
332
A Coruña, Barcelona, Madrid, Málaga, Murcia, Palma de Mallorca, Seville
2026-08-26
Recruiting
Dynamic Non-invasive Monitoring of Inspiratory Effort
NCT07839949Respiratory Mechanics, Monitoring, Physiologic, Respiratory Insufficiency Requiring Mechanical Ventilation, Critical Illness
Fundació d'investigació Sanitària de les Illes Balears
Observational
120
Palma de Mallorca
2026-08-04
Recruiting
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
NCT07690436Transthyretin Amyloid Cardiomyopathy
AstraZeneca
Observational
500
L'Hospitalet de Llobregat, Madrid, Palma de Mallorca
2026-07-08
Recruiting
Hospital Son Llatzer
Observational
50
Palma de Mallorca
2026-06-15
Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
NCT07504458Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Quetzal Therapeutics
Phase 3
150
Palma de Mallorca, Badalona, Barcelona, Cáceres, Málaga, Oviedo, Valencia
2026-06-08
Not yet open
Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia
NCT07384702Bacteremia Due to Staphylococcus Aureus
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 2
230
Alicante, Barcelona, Córdoba, Granada, Jerez de la Frontera, Madrid, Palma de Mallorca, Seville
2026-06
Recruiting
Incyte Corporation
Phase 3
588
Badalona, Barcelona, Las Palmas de Gran Canaria, Madrid, Palma de Mallorca, Santander, Seville, Valencia
2026-04-09
Recruiting
Incyte Corporation
Phase 3
700
Badalona, Barcelona, Las Palmas de Gran Canaria, Madrid, Majadahonda, Palma de Mallorca, Pamplona, Pozuelo de Alarcón
2026-03-05
Recruiting
Evaluation of a Multicomponent Early Intervention for Childhood Obesity Prevention in Vulnerable Families
NCT07529704Obesity & Overweight, Vulnerable Families, Children, Families With Infants
Helena Vall Roqué
Not applicable
526
Burgos, Barcelona, Palma de Mallorca, Seville
2026-03-02
Not yet open
Fundació Sant Joan de Déu
Not applicable
40
Palma de Mallorca
2026-03-01
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Barcelona, Lleida, Palma de Mallorca
2026-03-01
Recruiting
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Observational
100
A Coruña, Palma de Mallorca, Badalona, Barcelona, L'Hospitalet de Llobregat, Sant Joan Despí, Santander, Jerez de la Frontera
2026-02-15
Recruiting
Kardigan, Inc.
Phase 2/3
332
Horta-Guinardó, Majadahonda, A Coruña, Barcelona, Málaga, Murcia, Palma de Mallorca, Seville
2026-02-13
Recruiting
Eli Lilly and Company
Phase 3
900
A Coruña, Almería, Barcelona, Ferrol, Palma de Mallorca, Pozuelo de Alarcón, Santander, Seville
2026-02-10
Recruiting
Alnylam Pharmaceuticals
Phase 3
125
Barcelona, Huelva, L'Hospitalet de Llobregat, Madrid, Palma de Mallorca
2026-02-03
Recruiting
Takeda
Phase 3
183
Madrid, Marbella, Palma de Mallorca, Salamanca, Valencia
2026-01-14
Recruiting
Insmed Incorporated
Phase 3
344
Palma de Mallorca, L'Hospitalet de Llobregat, Majadahonda, Barcelona, Madrid, Santiago de Compostela, Seville, Toledo
2026-01-07
Active, closed
Hospital Son Llatzer
Observational
80
Palma de Mallorca, Sabadell
2026-01-01
Recruiting
Norgine
Phase 3
212
Ferrol, Palma de Mallorca, Sabadell, Madrid, Málaga
2025-12-29
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Palma de Mallorca, Badalona, Barcelona, Sabadell, Granada, Las Palmas de Gran Canaria, Lugo, Madrid
2025-12-22
Recruiting
Grupo Español de Investigación en Neurooncología
Phase 2
56
Palma de Mallorca, Barcelona, Barakaldo, Granada, Madrid, Vigo, Salamanca, Seville
2025-12-19
Recruiting
Janssen Research & Development, LLC
Observational
380
Córdoba, Jerez de la Frontera, Lugo, Málaga, Ourense, Palma de Mallorca, Santiago de Compostela, Seville
2025-12-03
Recruiting
Genmab
Phase 3
660
Palma de Mallorca, Barcelona, Girona, A Coruña, Madrid, Málaga, Pamplona, Valencia
2025-11-28
Recruiting
Summit Therapeutics
Phase 3
600
A Coruña, Barcelona, Córdoba, Granada, Madrid, Málaga, Palma de Mallorca, Santander
2025-11-18
Recruiting
Boehringer Ingelheim
Phase 3
670
A Coruña, Barcelona, Girona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Palma de Mallorca
2025-11-07
Recruiting
Hoffmann-La Roche
Phase 3
600
Palma de Mallorca, Santander, Las Palmas de Gran Canaria, Pamplona, Barcelona, Madrid, Málaga, Seville
2025-10-24
Recruiting
GlaxoSmithKline
Phase 3
1,196
Barcelona, Málaga, Palma de Mallorca
2025-10-20
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Barcelona, A Coruña, Madrid, Vigo, Seville, El Palmar, Palma de Mallorca, Salamanca
2025-10-06
Recruiting
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
NCT07040774Genetic Disease, Immune Dysfunction, Neurological Diseases or Conditions, Autoimmune Diseases
Imagine Institute
Observational
500
Barcelona, Palma de Mallorca
2025-10-01
Recruiting
Daiichi Sankyo
Phase 3
710
A Coruña, El Palmar, Madrid, Palma de Mallorca
2025-09-30
Recruiting
BeOne Medicines
Phase 3
500
Badalona, Burgos, Las Palmas de Gran Canaria, Madrid, Majadahonda, Palma de Mallorca, Seville
2025-09-04
Not yet open
Implementation of a Diabetic Foot Prevention Strategy in Primary Care (iMplanta Study)
NCT07004179Diabetic Foot Disease, Diabetic Foot Ulcer (DFU)
University of the Balearic Islands
Not applicable
1,520
Palma de Mallorca
2025-09-01
Not yet open
Universitat de les Illes Balears
Not applicable
74
Palma de Mallorca
2025-09-01
Not yet open
University of the Balearic Islands
Not applicable
139
Palma de Mallorca
2025-09
By invitation
Outcomes'10
Observational
132
Alicante, Madrid, Oviedo, Palma de Mallorca
2025-08-15
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
400
Madrid, Palma de Mallorca, Pontevedra
2025-08-08
Recruiting
Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic
NCT05955846Intraocular Lens, Cataract, Presbyopia
Z Optics, Inc.
Not applicable
60
Alicante, Ceuta, Córdoba, Madrid, Palma de Mallorca
2025-08-07
Recruiting
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
80
Seville, Zaragoza, Palma de Mallorca, Burgos, Salamanca, Badalona, Barcelona, Cáceres
2025-08-04
Recruiting
Hoffmann-La Roche
Observational
700
Almería, Palma de Mallorca, Manresa, Puerto Real, Alcázar de San Juan, Santiago de Compostela, Oviedo, Reus
2025-07-15
Active, closed
ViiV Healthcare
Phase 1
107
Pozuelo de Alarcón, Barcelona, Córdoba, La Laguna Santa Cruz, Madrid, Palma de Mallorca, Seville, Valencia
2025-07-10
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
450
Barcelona, Palma de Mallorca
2025-07-08
Active, closed
Upstream Bio Inc.
Phase 2
666
Palma de Mallorca, Torrelavega, Jerez de la Frontera, Cáceres, Granada, Madrid, Pozuelo de Alarcón, Benalmádena
2025-07-02
Not yet open
Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project
NCT07011368Obesity Prevention, Obesity and Overweight, Obesity and Obesity-related Medical Conditions, Digital Health
Fundació d'investigació Sanitària de les Illes Balears
Not applicable
2,720
Palma de Mallorca, Castelldefels, Zaragoza
2025-07-01
Recruiting
Idoven 1903 S.L.
Observational
2,200
Palma de Mallorca, San Sebastián, Huelva
2025-05-27
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Salamanca, A Coruña, Barcelona, Málaga, Palma de Mallorca, Zaragoza
2025-05-21
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
Eidos Therapeutics, a BridgeBio company
Phase 3
587
A Coruña, Barcelona, Huelva, Majadahonda, Palma de Mallorca, Salamanca
2025-05-12
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Alicante, Barcelona, Girona, Lleida, Madrid, Palma de Mallorca, Tarragona, Valencia
2025-05-05
Active, closed
General Practitioners Research Institute
Not applicable
746
Palma de Mallorca
2025-05-01
Recruiting
Persei Vivarium
Not applicable
196
Ferrol, Palma de Mallorca
2025-04-15
Recruiting
AstraZeneca
Phase 3
600
A Coruña, Córdoba, Donostia / San Sebastian, El Palmar, L'Hospitalet de Llobregat, Madrid, Palma de Mallorca, Valencia
2025-03-27
Recruiting
AstraZeneca
Phase 3
990
Barakaldo, Barcelona, Granada, Madrid, Málaga, Palma de Mallorca, Pamplona, Seville
2025-03-18
Recruiting
Maria Joyera Rodríguez
Phase 4
135
Barcelona, Palma de Mallorca
2025-02-12
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
AstraZeneca
Phase 1/2
408
Barcelona, Madrid, Palma de Mallorca, Santiago de Compostela, Valencia
2025-01-30
Recruiting
Universitat de les Illes Balears
Not applicable
60
Palma de Mallorca
2025-01-16
Recruiting
Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
NCT06955221Endometrioma, Ultrasound Therapy; Complications, Quality of Life, Pelvic Pain
Hospital Universitari de Bellvitge
Not applicable
288
Palma de Mallorca, Badalona, Igualada, L'Hospitalet de Llobregat, Martorell, Sabadell, Sant Boi de Llobregat, Viladecans
2025-01-01
Active, closed
mAbxience Research S.L.
Phase 3
726
A Coruña, Barcelona, Madrid, Málaga, Murcia, Oviedo, Palma de Mallorca, Pontevedra
2024-12-30
Active, closed
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Phase 2
28
Palma de Mallorca, Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Lleida, Tarragona, Terrassa
2024-12-16
Recruiting
OSE Immunotherapeutics
Phase 3
363
Palma de Mallorca, Badalona, L'Hospitalet de Llobregat, Barakaldo, A Coruña, Las Palmas de Gran Canaria, Majadahonda, Marbella
2024-12-03
Recruiting
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
45
A Coruña, Palma de Mallorca, Santander, Salamanca, Barcelona, L'Hospitalet de Llobregat, San Sebastián, Las Palmas de Gran Canaria
2024-11-20
Recruiting
University of the Balearic Islands
Not applicable
600
Palma de Mallorca
2024-10-25
Active, closed
University of the Balearic Islands
Not applicable
93
Palma de Mallorca, Sabadell
2024-09-30
Recruiting
Fundació d'investigació Sanitària de les Illes Balears
Not applicable
92
Palma de Mallorca
2024-09-27
Recruiting
Paulo Andrés Cano Jiménez
Not applicable
46
Palma de Mallorca
2024-08-15
Recruiting
General Practitioners Research Institute
Not applicable
900
Palma de Mallorca
2024-08-05
Recruiting
GlaxoSmithKline
Phase 3
150
Barcelona, Benalmádena, Madrid, Palma de Mallorca, Santander
2024-07-19
Active, closed
Eli Lilly and Company
Phase 3
10,000
A Coruña, Almería, Alzira, Barcelona, Ferrol, Málaga, Oviedo, Palma de Mallorca
2024-04-30
Recruiting
Fundación para la Investigación del Hospital Clínico de Valencia
Observational
70
Alicante, Badajoz, Barcelona, Candelaria, Castellon, Málaga, Murcia, Palma de Mallorca
2024-03-21
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Mirati Therapeutics Inc.
Phase 2
200
Santiago de Compostela, Málaga, Palma de Mallorca, Oviedo, Barcelona, Madrid, Seville, Valencia
2024-02-01
Not yet open
Fundacion Clinic per a la Recerca Biomédica
Early Phase 1
40
Santiago de Compostela, Barcelona, Madrid, Murcia, Oviedo, Palma de Mallorca, Salamanca
2024-01-15
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Barcelona, Palma de Mallorca, Santander, Valencia
2023-12-20
Recruiting
Intellia Therapeutics
Phase 3
1,200
A Coruña, Barcelona, Majadahonda, Málaga, Palma de Mallorca
2023-12-13
Active, closed
PETHEMA Foundation
Phase 2
50
Santiago de Compostela, Palma de Mallorca, Badalona, Santander, Jerez de la Frontera, Las Palmas de Gran Canaria, El Palmar, Barcelona
2023-11-23
Recruiting
Amgen
Phase 3
750
Málaga, Seville, Zaragoza, Palma de Mallorca, Las Palmas de Gran Canaria, Santander, Valladolid, Barcelona
2023-11-16
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Alcorcón, Alicante, Barcelona, Bilbao, Madrid, Palma de Mallorca, Santiago de Compostela, Seville
2023-10-12
Recruiting
AstraZeneca
Phase 3
800
A Coruña, Barcelona, Córdoba, Girona, Hospitalet deLlobregat, Madrid, Palma de Mallorca, Valencia
2023-09-22
Recruiting
Biotest
Phase 3
590
Palma de Mallorca, Sabadell, Terrassa, Córdoba, Majadahonda, Pamplona, Oviedo, Barcelona
2023-09-09
Active, closed
Fundació d'investigació Sanitària de les Illes Balears
Phase 3
110
Granada, Palma de Mallorca, Barcelona, Madrid, Murcia, Salamanca, Pontevedra, Zaragoza
2023-09-01
Active, closed
Cytokinetics
Phase 3
500
A Coruña, Barcelona, Madrid, Málaga, Murcia, Palma de Mallorca, Salamanca, Seville
2023-08-31
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Mérida, Palma de Mallorca, Santander, Santiago de Compostela, Torrejón de Ardoz, Benalmádena Costa, Alzira, Barcelona
2023-06-28
Active, closed
Alfasigma S.p.A.
Observational
509
Barcelona, Badalona, Las Palmas de Gran Canaria, Palma de Mallorca, Santiago de Compostela
2023-06-12
Active, closed
University Hospital Virgen de las Nieves
Observational
287
Granada, Logroño, Murcia, Cadiz, Córdoba, Jaén, Madrid, Palma de Mallorca
2023-06-01
Recruiting
Fundación Española de Hematología y Hemoterapía
Observational
210
Vitoria-Gasteiz, Almería, Palma de Mallorca, Sabadell, Burgos, Valdepeñas, Girona, Granada
2023-05-30
Active, closed
Janssen Research & Development, LLC
Phase 2
68
Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Málaga, Palma de Mallorca, Santiago de Compostela
2023-05-18
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Badalona, Jerez de la Frontera, L'Hospitalet de Llobregat, León, Madrid, Murcia, Oviedo, Palma de Mallorca
2023-03-29
Recruiting
High Definition Medicine for Solid Tumors Oncology
NCT06590506Metastatic Solid Tumor, Advanced Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III
Observational
300
A Coruña, Fuenlabrada, Palma de Mallorca, Pamplona, Seville, Barcelona, Cáceres, Madrid
2023-03-02
Recruiting
GBG Forschungs GmbH
Phase 2
170
Barcelona, Granada, Lleida, Madrid, Murcia, Palma de Mallorca, Santander, Seville
2023-01-02
Active, closed
Exelixis
Phase 3
317
Palma de Mallorca, Majadahonda, Barcelona, Córdoba, Girona, Madrid, Málaga, Oviedo
2023-01-01
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Palma de Mallorca, Ponferrada, Torrejón de Ardoz, Benalmádena Costa, Barcelona, Seville, Valencia
2022-12-29
Active, closed
PETHEMA Foundation
Phase 2
140
Madrid, Palma de Mallorca, Pamplona, Salamanca, San Cristóbal de La Laguna, Santander, Seville, Valencia
2022-12-15
Recruiting
AstraZeneca
Phase 3
3,527
Barcelona, Madrid, Majadahonda, Málaga, Ourense, Palma de Mallorca, Pamplona, Santander
2022-12-13
Active, closed
AstraZeneca
Phase 3
1,174
Barcelona, Bilbao (Vizcaya), Elche(Alicante), Madrid, Málaga, Palma de Mallorca, Toledo, Valencia
2022-11-28
Active, closed
Mirati Therapeutics Inc.
Phase 2
90
A Coruña, Madrid, Majadahonda, Palma de Mallorca, Seville, Zaragoza
2022-11-22
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
Hoffmann-La Roche
Observational
6,000
Palma de Mallorca, Granollers, L'Hospitalet de Llobregat, Ferrol, Santiago de Compostela, Logroño, Las Palmas de Gran Canaria, Marbella
2022-11-21
Active, closed
University Medical Center Groningen
Phase 3
1,750
Barcelona, Lleida, Madrid, Palma de Mallorca, Pamplona, Valencia
2022-11-08
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Badalona, Barcelona, Granada, Jerez de la Frontera, Madrid, Palma de Mallorca, Pozuelo de Alarcón, Salamanca
2022-10-25
Active, closed
AstraZeneca
Phase 3
607
Barcelona, Palma de Mallorca
2022-09-12
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
United Therapeutics
Phase 3
1,850
Santiago de Compostela, Palma de Mallorca, L'Hospitalet de Llobregat, Málaga, Oviedo, Barcelona, Granada, Madrid
2022-09-06
Active, closed
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
NCT05403385Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer
iTeos Therapeutics
Phase 2
36
Palma de Mallorca, Pamplona, Valencia, A Coruña, Badajoz, Barcelona, Manresa, Ourense
2022-08-26
Recruiting
Fundacion Clinic per a la Recerca Biomédica
Phase 4
360
Alicante, Seville, Palma de Mallorca, Barcelona, Sabadell, Terrassa, Barakaldo, Santander
2022-08-17
Recruiting
Bristol-Myers Squibb
Observational
1,700
Palma de Mallorca, Majadahonda, El Palmar, Oviedo, Burgos, Madrid, Málaga
2022-08-16
Active, closed
Incyte Corporation
Phase 1/2
53
Palma de Mallorca, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca, Seville, Valencia
2022-07-19
Recruiting
Neck Evolution With Ovation in Spain
NCT05823519Abdominal Aortic Aneurysm
DGM Vascular
Observational
120
Palma de Mallorca, Girona, Barakaldo, Burgos, Salamanca, Toledo, Gijón, Barcelona
2022-06-01
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
1,100
Palma de Mallorca, Badalona, L'Hospitalet de Llobregat, Barcelona, Granada, León, Madrid, Salamanca
2022-05-03
Active, closed
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 4
306
Palma de Mallorca, L'Hospitalet de Llobregat, Sabadell, Barakaldo, Jerez de la Frontera, Puerto Real, Donostia / San Sebastian, Logroño
2022-04-28
Active, closed
ARCAGY/ GINECO GROUP
Phase 3
260
Elche, Badalona, Córdoba, León, Palma, Palma de Mallorca, Santiago de Compostela, Valencia
2022-04-15
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Málaga, Palma de Mallorca, EI Palmar, Barcelona, Cáceres, Madrid, Valencia, La Laguna Tenerife
2022-03-07
Active, closed
Annetine Gelijns
Not applicable
450
Palma de Mallorca, Vigo, Barcelona, Madrid, Oviedo
2022-02-21
Active, closed
AstraZeneca
Phase 3
791
Bilbao (Vizcaya), Castellon, Córdoba, El Palmar, Palma de Mallorca, Sabadell (Barcelona)
2022-02-18
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
151
Madrid, Palma de Mallorca
2022-01-04
Active, closed
PETHEMA Foundation
Phase 1/2
60
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Palma de Mallorca, Pamplona
2021-12-20
Active, closed
European Association of Urology Research Foundation
Observational
1,076
Barcelona, Boadilla del Monte, Madrid, Majadahonda, Móstoles, Palma de Mallorca, Santander
2021-11-19
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Palma de Mallorca, Santiago de Compostela, Madrid, Majadahonda, Pamplona, Valencia
2021-10-27
Recruiting
Spanish Registry of Patients With IgM Monoclonal Gammopathies
NCT05093153Waldenstrom Macroglobulinemia
Fundación Española de Hematología y Hemoterapía
Observational
1,000
Mérida, Palma, Palma de Mallorca, Badalona, Barcelona, Manresa, Sabadell, Córdoba
2021-10-01
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Huelva, Oviedo, Palma de Mallorca, Villarreal, Barcelona, Madrid
2021-09-21
Active, closed
Orthofix Inc.
Observational
2,000
Barcelona, Palma de Mallorca, Santander
2021-09-15
Recruiting
EDUARDO ALBENIZ
Observational
1,200
Palma de Mallorca, Porto Cristo, Granollers, Terrassa, Aranda de Duero, Mérida, Ourense, Majadahonda
2021-09-09
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Elche, Palma de Mallorca, Badalona, Manresa, Sabadell, Santiago de Compostela, Jerez de la Frontera, Castellon de LA Plana/castello de LA Plana
2021-08-27
Active, closed
Inventiva Pharma
Phase 3
1,000
Almería, Badalona, Palma de Mallorca, Barcelona, Sabadell, León, Madrid, Majadahonda
2021-08-19
Recruiting
Hospital Son Llatzer
Not applicable
40
Palma de Mallorca
2021-08-01
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Elche, Palma de Mallorca
2021-07-13
Active, closed
Nobel Biocare
Observational
1,000
Barcelona, Málaga, Palma de Mallorca
2021-05-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Palma de Mallorca, Santander, Barcelona, Majadahonda, Madrid, Toledo
2021-05-12
Recruiting
Spanish Series of Patients Treated With the Radionuclide Lutetium177
NCT04949282Neuroendocrine Tumors, Intestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms
Sociedad Española de Medicina Nuclear e Imagen Molecular
Observational
5,000
Santiago de Compostela, Granada, Palma de Mallorca, L'Hospitalet de Llobregat, Getafe, Majadahonda, El Palmar, Pamplona
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 3
557
Palma de Mallorca, Santiago de Compostela, Pamplona/iruña, Córdoba, Madrid, Valencia, Zaragoza
2021-04-26
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Málaga, Barcelona, L'Hospitalet de Llobregat, Pamplona, Palma de Mallorca, Madrid, Valencia
2021-04-08
Active, closed
PETHEMA Foundation
Phase 2
50
Palma de Mallorca, Santander, Salamanca, Santiago de Compostela, Madrid, Gijón, Valencia, Las Palmas de Gran Canaria
2021-04-07
Recruiting
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT04766866Preeclampsia, Intrauterine Growth Restriction, Maternal Hypertension, Neonatal Outcome
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Not applicable
9,132
Badalona, Las Palmas de Gran Canaria, El Palmar, Barcelona, Madrid, Palma de Mallorca, Valencia, Zaragoza
2021-03-02
Active, closed
Celgene
Phase 3
313
Barcelona, Granada, Las Palmas de Gran Canaria, Madrid, Palma de Mallorca, Salamanca, Santiago de Compostela, Seville
2021-02-25
Active, closed
BioNTech SE
Phase 2/3
358
Barcelona, Girona, Jaén, Madrid, Majadahonda, Málaga, Palma de Mallorca, Valencia
2021-01-07
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
68
L'Hospitalet de Llobregat, Barcelona, Madrid, Palma de Mallorca, Pamplona, Seville
2020-11-17
Active, closed
Bayer
Phase 4
654
Santiago de Compostela, Palma de Mallorca, Badalona, Castellon, Majadahonda, Oviedo, A Coruña, Barcelona
2020-11-09
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Palma de Mallorca, Las Palmas, Córdoba, Madrid, Valladolid
2020-11-04
Active, closed
Bayer
Phase 3
402
Elche, Manacor, Palma de Mallorca, Sabadell, Alcorcón, Barcelona, Cáceres, Córdoba
2020-10-20
Active, closed
Exelixis
Phase 3
575
Elche, Palma de Mallorca, Manresa, Santiago de Compostela, Alcorcón, Oviedo, Badalona, Barcelona
2020-10-19
Active, closed
GlaxoSmithKline
Phase 3
302
Barcelona, Gijón, L'Hospitalet de Llobrega, Madrid, MOstoles Madrid, Murcia, Palma de Mallorca, PamplonaNavarra
2020-10-01
Recruiting
Mats Heyman
Phase 3
6,430
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Palma de Mallorca, Seville, Valencia, Zaragoza
2020-07-13
Active, closed
Baxalta now part of Shire
Observational
207
Palma de Mallorca, Barcelona, Las Palmas, Madrid, Málaga
2020-07-09
Active, closed
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
NCT04223596Lung Cancer, NSCLC, NSCLC Stage IIIB, NSCLC Stage IV
Fundación GECP
Phase 2
33
A Coruña, Alicante, Málaga, Palma de Mallorca, Badalona, L'Hospitalet de Llobregat, Barcelona, Las Palmas de Gran Canaria
2020-05-04
Recruiting
Spanish Registry of Esophagogastric Cancer
NCT04958720Esophageal Cancer, Gastric Cancer
Fundación Sociedad Española de Oncologia Médica
Observational
10,000
Alicante, Elche, Elda, Córdoba, Málaga, Seville, Palma de Mallorca, Barcelona
2020-04-27
Active, closed
Eli Lilly and Company
Phase 3
261
Palma de Mallorca, Badalona, Santiago de Compostela, Las Palmas de Gran Canaria, Majadahonda, Pamplona, Alicante, Barcelona
2020-02-17
Active, closed
Registry Study of Pregnancy and Breast Cancer
NCT04603820Breast Cancer and Pregnancy
Spanish Breast Cancer Research Group
Observational
866
Palma de Mallorca, Badalona, Terrassa, Bilbao, Santa Cruz de Tenerife, A Coruña, Las Palmas de Gran Canaria, Leganés
2019-11-18
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Palma de Mallorca, Barcelona, San Cristóbal de La Laguna, Córdoba, Madrid, Sant Joan Despí, Seville, Valencia
2019-10-02
Recruiting
Mats Heyman
Observational
500
Alicante, Barakaldo, Barcelona, Fuencarral-El Pardo, Madrid, Murcia, Palma de Mallorca, Santander
2019-08-29
Active, closed
Overweight and Obesity in Preschoolers
NCT03800823Obesity, Overweight
Karolinska Institutet
Not applicable
300
Palma de Mallorca
2019-02-15
Recruiting
RECORDATI GROUP
Observational
95
Barcelona, Bilbao, Madrid, Murcia, Palma de Mallorca, Seville, Zaragoza
2019-01-15
Recruiting
Periprosthetic Fracture Registry (PPFx)
NCT03378557Periprosthetic Fractures, Periprosthetic Fracture Around Prosthetic Joint Implant
AO Innovation Translation Center
Observational
600
Palma de Mallorca
2018-12-31
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Palma de Mallorca, Sagunto, Barcelona, Madrid, Seville, Valencia, Zaragoza
2018-12-11
Active, closed
AbbVie
Phase 3
265
Palma de Mallorca, Marbella, Ourense, San Cristóbal de La Laguna, Barcelona, Girona, León, Madrid
2018-10-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Palma, Palma de Mallorca, L'Hospitalet de Llobregat, San Sebastian- Donostia, Santander, Badalona, Barcelona, Santiago de Compostela
2018-08-21
Active, closed
pharmaand GmbH
Phase 3
1,097
Barcelona, Bilbao, Castillón, El Palmar, Jerez de la Frontera, Madrid, Oviedo, Palma de Mallorca
2018-05-14
Active, closed
AbbVie
Phase 3
747
Palma de Mallorca, Santander, Las Palmas de Gran Canaria, Pamplona, A Coruña, Barcelona, Girona, Huelva
2018-03-21
Active, closed
AstraZeneca
Phase 2
273
Barcelona, Cáceres, Madrid, Palma de Mallorca, San Sebastián, Sant Cugat del Vallès, Seville, Valencia
2018-03-07
Recruiting
Octapharma
Observational
200
Alicante, Barcelona, Málaga, Palma de Mallorca, Valencia
2018-02-13
Active, closed
Hoffmann-La Roche
Phase 3
382
Palma de Mallorca, Córdoba, A Coruña, Las Palmas de Gran Canaria, Pamplona, Barcelona, Cáceres, Jaén
2017-09-20
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
Exelixis
Phase 1
914
Santiago de Compostela, Elche, Palma de Mallorca, Badalona, Sabadell, Jeréz de La Frontera, Pamplona, Oviedo
2017-09-05
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
Institut de Recherches Internationales Servier
Phase 3
146
Santiago de Compostela, Palma de Mallorca, Badalona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville, Valencia
2017-06-26
Active, closed
Tesaro, Inc.
Phase 1
463
Barcelona, Girona, Jerez de la Frontera, L'Hospitalet de Llobrega, Las Palmas de Gran Canar, Madrid, Málaga, Palma de Mallorca
2016-07-08
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Barcelona, Palma de Mallorca
2016-06
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Pfizer
Phase 3
1,068
Palma de Mallorca, Manresa, Santiago de Compostela, Barcelona, Cadiz, Girona, Madrid, Ourense
2014-12-17
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Badalona, Barcelona, Madrid, Palma de Mallorca, Pamplona, Salamanca, Seville
2014-11
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma, Liposarcoma
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
199
Zaragoza, Barcelona, Palma de Mallorca, San Cristóbal de La Laguna, Madrid, Seville
2014-11
Active, closed
AbbVie
Observational
1,446
A Coruña, Ferrol, Santiago de Compostela, Palma de Mallorca, Badalona, Esplugues de Llobregat, Sabadell, Leganés
2014-08-28
Active, closed
AbbVie
Observational
8,250
A Coruña, Ferrol, Santiago de Compostela, Elche, Sant Joan d'Alacant, Manacor, Palma de Mallorca, Badalona
2013-04-29
Active, closed
PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty
NCT03372278Rheumatoid Arthritis With Adequate Bone Quality, Inflammatory Arthritis, Osteoarthritis, Hip, Avascular Necrosis
Zimmer Biomet
Observational
250
Palma de Mallorca
2013-01
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Badajoz, Barakaldo, Barcelona, Burgos, Madrid, Palma de Mallorca, Pamplona, Valencia
2012-07
Recruiting
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735Chronic Myeloid Leukemia
Poitiers University Hospital
Observational
750
Palma de Mallorca
2011-01
Recruiting
Medtronic
Observational
20,000
A Coruña, Barcelona, Córdoba, Girona, Granada, Madrid, Palma de Mallorca, Salamanca
1983-01
Rows per page Showing 1–173 of 173
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-spain/city/palma-de-mallorca

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 173 of those studies with a site in Palma de Mallorca.

How many clinical trials are recruiting in Palma de Mallorca?

81 of the 173 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 11 have not yet opened recruitment, 79 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Palma de Mallorca), 173 studies
PhaseStudiesRecruitingShare
Phase 3753443.4%
Observational402523.1%
Not applicable221212.7%
Phase 221512.1%
Phase 4522.9%
Phase 1/2422.3%
Phase 1301.7%
Phase 2/3211.2%
Early Phase 1100.6%

Most active sponsors

Lead sponsors with the most studies (Palma de Mallorca)
Lead sponsorStudiesRecruiting
AstraZeneca106
Hoffmann-La Roche82
Fundació d'investigació Sanitària de les Illes Balears52
Janssen Research & Development, LLC52
AbbVie40
PETHEMA Foundation40
University of the Balearic Islands41
Eli Lilly and Company31
Exelixis30
GlaxoSmithKline32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.